Your browser doesn't support javascript.
loading
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.
Chim, C S; Kumar, S K; Orlowski, R Z; Cook, G; Richardson, P G; Gertz, M A; Giralt, S; Mateos, M V; Leleu, X; Anderson, K C.
  • Chim CS; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong.
  • Kumar SK; Department of Medicine, Mayo Clinic at Rochester, Rochester, MN, USA.
  • Orlowski RZ; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cook G; Haematology & Myeloma Studies, Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Gertz MA; Department of Medicine, Mayo Clinic at Rochester, Rochester, MN, USA.
  • Giralt S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Mateos MV; Department of Haematology, University Hospital of Salamanca, Salamanca, Spain.
  • Leleu X; Hopital La Mileterie, part of the Academic Hospital of Poitiers (CHU), France.
  • Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Leukemia ; 32(2): 252-262, 2018 02.
Article en En | MEDLINE | ID: mdl-29257139
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos / Mieloma Múltiple / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos / Mieloma Múltiple / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article